Cardiff oncology inc CRDF.US Value Analysis
CRDF Value Score
3
24
15
- AI analysis rates CRDF with a medium value score of 3.
- It is mainly due to stable revenue growth, but with concerns regarding unstable operating cash flow.
- Over the past 3 months, CRDF has maintained a consecutive value rating of 3.0, close to the rating of 3.1 over the past 3 years, indicating stable enterprise value.
- Compared to all stocks in the Health Care sector, CRDF has a medium value rating.
CRDF Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2024/11/15 (Weekly Update)
CRDF Financial Forecast
Unit : USD
Update to 2025/5/13 (Quarterly Update)
CRDF Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -0.21 | 0% | -19.2% | 151K | -3.2% | 60.3% | -7,184.8% |
| 2024Q2 | -0.25 | -13.6% | -7.4% | 165K | 17% | 135.7% | -7,225.8% |
| 2024Q1 | -0.26 | -4% | 4% | 163K | 50.9% | 171.7% | -4,883.4% |
| 2023Q4 | -0.22 | 12% | -12% | 205K | 147% | 192.9% | -5,985.3% |
| 2023Q3 | -0.21 | -5% | -19.2% | 156K | 21.9% | 290% | -6,901.4% |
Update to 2025/5/14 (Quarterly Update)
CRDF Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
CRDF Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
The Backtest Result of CRDF from 2012/08 till Now
- -80.90%
- Cumulative Return
- -12.20%
- Annual Return
- 71.62%
- Volatility
- -0.17
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from August, 2012 to May, 2025. (Total Trades: 2)
| CRDF | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 45% | 54% |
| Avg Return | -48.3% | 63.1% | 75% |
| Avg Profit | - | 197% | 167.9% |
| Avg Loss | -48.3% | -44.8% | -34.5% |
| Avg Risk-Reward Ratio | - | 440% | 486.6% |
Update to 2025/5/14 (Daily Update)